SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?


To: Shack who wrote (761)7/11/2000 12:10:58 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 783
 
06:22 ET Maxim Pharmaceuticals Inc. (MAXM) 56 1/4 : Drug company said on Tuesday it had licensed a series of anti-cancer compounds to biotechnology company BioChem Pharma (BCHE : 24 3/8). The agreement requires BioChem to make payments to Maxim totalling up to US$55 mln and calls for BioChem to pay a royalty on product sales resulting from the collaboration.

Breifing.com
Jim